Clinical trial shows experimental drug's ability to knock down pancreatic cancer's defense
By adding an experimental drug to a standard chemotherapy regimen, a subset of patients with metastatic pancreatic cancer had a significantly longer period before the cancer progressed as compared with those who received ...
May 31, 2017
0
1